Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products to meet important unmet medical needs in neurology and psychiatry. The company creates therapeutics by improving and expanding the uses of known compounds & aggressively adding to their pharmaceutical product portfolio through licensing, acquisitions and collaborations. It also develops and commercializes neurological and psychiatric products. The company was founded by Bruce C. Cozadd & Robert M. Myers in 2003 and is headquartered in Palo Alto, CA.